(New England Journal of Medicine) Patients at near-term risk of ventricular arrhythmias may be identified by an artificial intelligence-enabled single-lead ambulatory ECG. (European Heart Journal ...

In all, 149 out of the 323 patients in CRISP-AMI with baseline ECG and 6-month follow-up data had large STEMI, with 36 patients (n = 15 IABP and 21 control) also showing poor ST-segment resolution.

Aims There are few studies of the use of intra-aortic balloon pump (IABP) treatment as a bridge to heart transplantation (HTx). This is the first study to compare long-term clinical and ...

Similar to deleterious consequences of early balloon inflation Early deflation Reduced inflation time, leading to lower peak diastolic augmentation and suboptimal IABP function. Theoretically ...

Get Instant Summarized Text (Gist) Early use of an intra-aortic balloon pump (IABP) in patients with cardiogenic shock due to heart failure did not improve 60-day survival or facilitate transition ...

In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP ...

For the last 4 months, she was having CCS-4 angina. ECG showed NSR and nonspecific ST-T changes in all leads. 2D-echo was normal with a left ventricular ejection fraction of 65% and regional wall ...

Munich, Germany – A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used ...

Leveraging the patented technology of the AC3 Optimus™ IABP, the AC3 Range™ IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...